864055

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 12, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)